Select Publications

Book Chapters

Baysari M; Chan J; Carland J; Stocker S; Moran M; Day R, 2018, 'Usability of Reports Generated by a Computerised Dose Prediction Software', in Connecting the System to Enhance the Practitioner and Consumer Experience in Healthcare, IOS Press, Netherlands, pp. 27 - 32, http://dx.doi.org/10.3233/978-1-61499-890-7-27

Day R; pile KD; graham GG; katelaris C, 2016, 'Antimalarial Drugs', in Compendium of Inflammatory Diseases, Springer Basel, Basel, pp. 97 - 101, http://dx.doi.org/10.1007/978-3-7643-8550-7

Day R; graham GG, 2016, 'Coxibs', in Compendium of Inflammatory Diseases, Springer Basel, pp. 1 - 7, http://dx.doi.org/10.1007/978-3-0348-0620-6_22-1

Graham GG; Roberts MS; Day RO; Rainsford KD, 2016, 'Pharmacokinetics and metabolism of the salicylates', in Aspirin and Related Drugs, pp. 97 - 155

Day RO; Graham GG, 2013, 'Non-steroidal anti-inflammatory drugs', in Encyclopedia of Inflammatory Diseases, edn. 6, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Day RO; Graham GG; Williams KM, 2013, 'Propionic acid derivative drugs (Profens)', in Encyclopedia of Inflammatory Diseases, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Graham GG; Day RO, 2013, 'Salicylates', in Encyclopedia of Inflammatory Diseases, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Day RO; Williams KM; Graham GG, 2013, 'Urate-lowering therapy: Uricosurics', in Dalbeth N; Peresa-Ruiz F; Schlesinger N (ed.), Gout, Future Medicine Ltd, pp. 174 - 188, http://dx.doi.org/10.2217/ebo.13.104

Pile K; Graham GG; Mahler SM; Day RO, 2011, 'Disease modifying antirheumatic drugs', in Nijkamp FP; Parnham MJ (ed.), Principles of Immunopharmacology, edn. 3, Birkhauser Verlag (Springer), Basel, Switzerland, pp. 585 - 619, http://books.google.com.au/books?id=X0deXiGtcCAC&printsec=frontcover#v=onepage&q&f=false

Baysari MT; Westbrook J; Day RO, 2011, 'Medication decision-making on hospital ward-rounds', in Moen A; Andersen SK; Aarts J; Hurlen P (ed.), Studies in Health Technology and Informatics, IOS Press, Amsterdam, pp. 935 - 939, http://dx.doi.org/10.3233/978-1-60750-806-9-935

Bachmeier CJ; Brooks PM; Day RO; Graham GG; Littlejohn GO; Morand E; Pile K; Williams KM, 2005, 'Disease-modifying anti-rheumatic drugs (DMARD)', in Nijkamp FJ; Parnham MJ (ed.), Principles of Immunopharmacology (2nd Ed), edn. 2nd, Birkhauser Verlag, Basel, pp. 511 - 544

Day RO, 2003, 'Therapy of osteoarthritis', in Scott D; Cope A (ed.), The Year in Rheumatic Disorders 2003, edn. First, Clinical Publishibg Services Ltd, Oxford, United Kingdom, pp. 23 - 34

Day RO; Quinn DE; Williams KK; Handel ML; Brooks PM, 2000, 'Connective tissue and bone disorders', in Melmon and Morrelli`s clinical pharmacology: basic principles in therapeutics, edn. Original, McGrath Hill, New York, pp. 645 - 702

Day RO, 2000, 'Rheumatic Disorders', in Melmon and Morrelli`s clinical pharmacology: basic principles in therapeutics, edn. Original, McGrath Hill, New York, pp. 645 - 702

Day RO; Quinn DI; March LM; Graham GG; Williams KM, 2000, 'Rheumatoid arthritis. New Frontiers in pathogenesis and treatment', in NSAIDs and analgesics, edn. Original, Oxford University Press, Oxford, England, pp. 307 - 328

Brady S; Day RO; Graham GG, 1999, 'Are Intra-Articular steroids as effective?', in Challenges in Rheumatoid Arthritis, edn. Original, Blackwell Science, Oxford, UK, pp. 174 - 189

Bachmeier CJ; Handel ML; Conaghan PG; Williams KM; Graham GG; Brooks PM; Day RO, 1999, 'Disease-modifying antirheumatic drugs', in Nijkamp FP; Parnham MJ (ed.), Principles of Immunopharmacology, edn. 3, Birkhauser Verlag (Springer), Basel, Switzerland, pp. 379 - 403

Graham GG; Milligan MK; Day RO; Williams KM; Ziegler JB, 1998, 'Therapeutic considerations from pharmacokinetics and metabolism: ibuprofen and paracetamol', in Rainsford KD; Powanda MC (ed.), Safety and Efficacy of non-prescription (OTC) analgesics and NSAIDs, Kluwer Academic Publishers, Dordrecht, pp. 77 - 92, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000081416000006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Brooks PM; Savdie E; Day RO, 1998, 'Antirheumatic drugs and renal disease', in Rheumatology (2nd Ed), edn. Original, Gower, London, pp. 28 - 29

Brooks PM; Day RO, 1998, 'Arthritis', in Drug Therapy in old age, edn. Original, Wiley & Sons, Chichester UK, pp. 387 - 400

Bachmeier CJ; Handel ML; Conaghan PG; Williams KM; Graham GG; Brooks PM; Day RO, 1998, 'Disease Modifying antirheumatic drugs', in Textbook of Immunopharmacology, edn. 3, Burkhauser, Basel, Switzerland, pp. 183 - 190, http://dx.doi.org/10.1097/00002281-199705000-00003

Day RO, 1998, 'Formulary and Guide to Prescribing (second edition)', in Formulary Guide to Prescribing (2nd Ed), edn. Original, St. Vincent's Hospital, Sydney, Australia, pp. 1 - 445

Yeomans N; Brooks PM; Day RO, 1998, 'Non steroidal anti-inflammatory drugs and peptic ulceration', in Rheumatology (2nd Ed), edn. Original, Gower, London, pp. 27 - 28

Day RO, 1998, 'SARDS', in Rheumatology (2nd Ed), edn. Original, Gower, London, pp. 8.1 - 8.10

Quinn DE; Day RO, 1997, 'Guide to Clinically More Important Drug Interactions.', in Drug Safety, edn. Original, Adis International Limited, Auckland, New Zealand, pp. 1665 - 1700

Day RO, 1997, 'Sulfasalazine.', in In: `The Textbook of Rheumatology`, Edition 5., edn. Original, pp. 741 - 746

Graham GG; Milligan MK; Day RO; Williams KM; Zeig , 1997, 'Therapeutic considerations from pharmacokinetics and metabolism: ibuprofen and paracetamol', in In: `Safety and efficacy of non-prescription (OTC) analgesics, edn. Original, Kluwer Academic Publishers, Great Britain, pp. 77 - 92

Journal articles

Ferraro MC; Bagg MK; Wewege MA; Cashin AG; Leake HB; Rizzo RRN; Jones MD; Gustin SM; Day R; Loo CK; McAuley JH, 2021, 'Efficacy, acceptability, and safety of antidepressants for low back pain: a systematic review and meta-analysis', Systematic Reviews, vol. 10, pp. 62, http://dx.doi.org/10.1186/s13643-021-01599-4

Westbrook JI; Li L; Raban MZ; Woods A; Koyama AK; Baysari MT; Day RO; McCullagh C; Prgomet M; Mumford V; Dalla-Pozza L; Gazarian M; Gates PJ; Lichtner V; Barclay P; Gardo A; Wiggins M; White L, 2021, 'Associations between double-checking and medication administration errors: A direct observational study of paediatric inpatients', BMJ Quality and Safety, vol. 30, pp. 320 - 330, http://dx.doi.org/10.1136/bmjqs-2020-011473

Chye A; Lin CWC; Hancock MJ; Harris I; Latimer J; Maher CG; McLachlan AJ; Mathieson S; Koes B; Day RO; Billot L; Jan S; Angell B, 2021, 'Healthcare expenditure and its predictors in a cohort of Australians living with sciatica', European Spine Journal, vol. 30, pp. 878 - 885, http://dx.doi.org/10.1007/s00586-020-06605-2

Braithwaite HE; Darley DR; Brett J; Day RO; Carland JE, 2021, 'Identifying the association between tacrolimus exposure and toxicity in heart and lung transplant recipients: A systematic review', Transplantation Reviews, vol. 35, http://dx.doi.org/10.1016/j.trre.2021.100610

Ghinea N; Critchley C; Morrell B; Kerridge I; Campbell T; Day R; Gazarian M; Isaacs D; Liauw W; Olver I; Pace J; Pearson S; Salkeld G; Lipworth W, 2021, 'A survey of Australian public attitudes towards funding of high cost cancer medicines', Health Policy, vol. 125, pp. 327 - 334, http://dx.doi.org/10.1016/j.healthpol.2020.12.002

Ryan AC; Carland JE; McLeay RC; Lau C; Marriott DJE; Day RO; Stocker SL, 2021, 'Evaluation of amikacin use and comparison of the models implemented in two Bayesian forecasting software packages to guide dosing', British Journal of Clinical Pharmacology, vol. 87, pp. 1422 - 1431, http://dx.doi.org/10.1111/bcp.14542

Baysari MT; Moran M; Del Gigante J; Day RO, 2021, 'Indications-based prescribing: A challenge for hospital prescribers', British Journal of Clinical Pharmacology, vol. 87, pp. 730 - 731, http://dx.doi.org/10.1111/bcp.14532

Premachandra KH; Day RO; Roberts DM, 2021, 'Managing hyperuricemia and gout in chronic kidney disease: a clinical conundrum', Current opinion in nephrology and hypertension, vol. 30, pp. 245 - 251, http://dx.doi.org/10.1097/MNH.0000000000000691

Sandaradura I; Wojciechowski J; Marriott DJE; Day RO; Stocker S; Reuter SE, 2021, 'Model-optimized fluconazole dose selection for critically ill patients improves early pharmacodynamic target attainment without the need for therapeutic drug monitoring', Antimicrobial Agents and Chemotherapy, vol. 65, http://dx.doi.org/10.1128/AAC.02019-20

Nathan N; Nguyen AD; Stocker S; Laba TL; Baysari MT; Day RO, 2021, 'Out-of-pocket spending among a cohort of Australians living with gout', International Journal of Rheumatic Diseases, vol. 24, pp. 327 - 334, http://dx.doi.org/10.1111/1756-185X.13979

Carland JE; Elhage T; Baysari MT; Stocker SL; Marriott DJE; Taylor N; Day RO, 2021, 'Would they trust it? An exploration of psychosocial and environmental factors affecting prescriber acceptance of computerised dose-recommendation software', British Journal of Clinical Pharmacology, vol. 87, pp. 1215 - 1233, http://dx.doi.org/10.1111/bcp.14496

MacHado GC; Abdel-Shaheed C; Underwood M; Day RO, 2021, 'Non-steroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain', The BMJ, vol. 372, pp. n104, http://dx.doi.org/10.1136/bmj.n104

Uster DW; Stocker SL; Carland JE; Brett J; Marriott DJE; Day RO; Wicha SG, 2021, 'A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing: Vancomycin as a Case Study', Clinical Pharmacology and Therapeutics, vol. 109, pp. 175 - 183, http://dx.doi.org/10.1002/cpt.2065

Roydhouse SA; Carland JE; Debono DS; Baysari MT; Reuter SE; Staciwa AJ; Sandhu APK; Day RO; Stocker SL, 2021, 'Accuracy of documented administration times for intravenous antimicrobial drugs and impact on dosing decisions', British Journal of Clinical Pharmacology, http://dx.doi.org/10.1111/bcp.14844

Carland JE; Stocker SL; Baysari MT; Li C; Själin J; Moran MA; Tang S; Sandaradura I; Elhage T; Gilbey T; Williams KM; Marriott DJE; Day RO, 2021, 'Are vancomycin dosing guidelines followed? A mixed methods study of vancomycin prescribing practices', British Journal of Clinical Pharmacology, http://dx.doi.org/10.1111/bcp.14834

Yeh MC; Wu BJ; Li Y; Elahy M; Prado-Lourenco L; Sockler J; Lau H; Day RO; Khachigian LM, 2021, 'BT2 suppresses human monocytic-endothelial cell adhesion, bone erosion and inflammation', Journal of Inflammation Research, vol. 14, pp. 1019 - 1028, http://dx.doi.org/10.2147/JIR.S296676

Sandaradura I; Marriott DJE; Day RO; Norris RLG; Pang E; Stocker SL; Reuter SE, 2021, 'Current fluconazole treatment regimens result in under-dosing of critically ill adults during early therapy', European Journal of Clinical Microbiology and Infectious Diseases, http://dx.doi.org/10.1007/s10096-021-04201-w

Stocker SL; Carland JE; Reuter SE; Stacy AE; Schaffer AL; Stefani M; Lau C; Kirubakaran R; Yang JJ; Shen CFJ; Roberts DM; Marriott DJE; Day RO; Brett J, 2021, 'Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series Analysis', Clinical Pharmacology and Therapeutics, vol. 109, pp. 212 - 221, http://dx.doi.org/10.1002/cpt.2113

Coleshill MJ; Aung E; Carland JE; Faasse K; Stocker S; Day RO, 2021, 'Rebranding Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy?', Therapeutic Innovation and Regulatory Science, vol. 55, pp. 138 - 141, http://dx.doi.org/10.1007/s43441-020-00198-0

Abdel Shaheed C; Ferreira G; Dmitritchenko A; McLachlan A; Day RO; Saragiotto B; Lin C; Langendyk V; Stanaway F; Latimer J; Kamper S; McLachlan H; Ahedi H; Maher CG, 2021, 'The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews', Medical Journal of Australia, http://dx.doi.org/10.5694/mja2.50992

Sarkies MN; Francis-Auton E; Long JC; Partington A; Pomare C; Nguyen HM; Wu W; Westbrook J; Day RO; Levesque JF; Mitchell R; Rapport F; Cutler H; Tran Y; Clay-Williams R; Watson DE; Arnolda G; Hibbert PD; Lystad R; Mumford V; Leipnik G; Sutherland K; Hardwick R; Braithwaite J, 2020, 'Implementing large-system, value-based healthcare initiatives: A realist study protocol for seven natural experiments', BMJ Open, vol. 10, pp. e044049 - e044049, http://dx.doi.org/10.1136/bmjopen-2020-044049

Kamel B; Graham GG; Stocker SL; Liu Z; Williams KM; Carland JE; Pile KD; Day RO, 2020, 'A pharmacokinetic-pharmacodynamic study of a single dose of febuxostat in healthy subjects', British Journal of Clinical Pharmacology, vol. 86, pp. 2486 - 2496, http://dx.doi.org/10.1111/bcp.14357

Milder TY; Stocker SL; Day RO; Greenfield JR, 2020, 'Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease', Drug Safety, vol. 43, pp. 1211 - 1221, http://dx.doi.org/10.1007/s40264-020-01010-6


Back to profile page